At a glance
- Originator Eli Lilly and Company
- Class Anti-ischaemics; Antidementias; Antiepileptic drugs; Antiparkinsonians; Isoquinolines; Neuroprotectants
- Mechanism of Action Glutamate receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Movement disorders
- Discontinued Alzheimer's disease